CoChat
Sign Up
Cited by 182

The DOI matches its Crossref record.

MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma

Wang, Wen, Zhao, Lan-Juan, Tan, Ye-Xiong, Ren, Hao, Qi, Zhong-Tian·2012·Carcinogenesis
DOI 10.1093/carcin/bgs113PMC PMC3334515
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/carcin/bgs113

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 52

  1. Parkin, 2002, Global cancer statistics, CA Cancer J. Clin., 55, 74, 10.3322/canjclin.55.2.74 · DOI
  2. Aravalli, 2008, Molecular mechanisms of hepatocellular carcinoma, Hepatology, 48, 2047, 10.1002/hep.22580 · DOI
  3. Nelson, 2008, MicroRNAs and cancer: past, present, and potential future, Mol. Cancer Ther., 7, 3655, 10.1158/1535-7163.MCT-08-0586 · DOI
  4. Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  5. He, 2004, MicroRNAs: small RNAs with a big role in gene regulation, Nat. Rev. Genet., 5, 522, 10.1038/nrg1379 · DOI · Paper page
  6. Calin, 2006, MicroRNA signatures in human cancers, Nat. Rev. Cancer, 6, 857, 10.1038/nrc1997 · DOI
  7. Esquela-Kerscher, 2006, Oncomirs—microRNAs with a role in cancer, Nat. Rev. Cancer, 6, 259, 10.1038/nrc1840 · DOI · Paper page
  8. Ashburner, 2000, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium, Nat. Genet., 25, 25, 10.1038/75556 · DOI · Paper page
  9. Dupuy, 2007, Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans, Nat. Biotechnol., 25, 663, 10.1038/nbt1305 · DOI
  10. Schlitt, 2003, From gene networks to gene function, Genome Res., 13, 2568, 10.1101/gr.1111403 · DOI
  11. Kanehisa, 2004, The KEGG resource for deciphering the genome, Nucleic Acids Res., 32, D277, 10.1093/nar/gkh063 · DOI
  12. Yi, 2006, WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data, BMC Bioinformatics, 7, 30, 10.1186/1471-2105-7-30 · DOI
  13. Draghici, 2007, A systems biology approach for pathway level analysis, Genome Res., 17, 1537, 10.1101/gr.6202607 · DOI
  14. Whittaker, 2010, The role of signaling pathways in the development and treatment of hepatocellular carcinoma, Oncogene, 29, 4989, 10.1038/onc.2010.236 · DOI
  15. Min, 2011, Mitogen-activated protein kinases in hepatocellular carcinoma development, Semin. Cancer Biol., 21, 10, 10.1016/j.semcancer.2010.10.011 · DOI
  16. Mishra, 2009, Liver stem cells and hepatocellular carcinoma, Hepatology, 49, 318, 10.1002/hep.22704 · DOI
  17. Takigawa, 2008, Wnt signaling in liver cancer, Curr. Drug Targets, 9, 1013, 10.2174/138945008786786127 · DOI
  18. Braconi, 2008, MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors, Hepatology, 47, 1807, 10.1002/hep.22326 · DOI
  19. Ladeiro, 2008, MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations, Hepatology, 47, 1955, 10.1002/hep.22256 · DOI · Paper page
  20. Mott, 2009, MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia, Hepatology, 50, 630, 10.1002/hep.23010 · DOI
  21. Shen, 2010, Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion, Mol. Cancer, 9, 227, 10.1186/1476-4598-9-227 · DOI
  22. Sakurai, 2011, MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feed back loop in a variety of human cancers, Cancer Res., 75, 1680, 10.1158/0008-5472.CAN-10-2345 · DOI
  23. Port, 2011, Micro-RNA expression in cisplatin resistant germ cell tumor cell lines, Mol. Cancer, 10, 52, 10.1186/1476-4598-10-52 · DOI
  24. Kim, 2010, Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours, Histopathology, 57, 734, 10.1111/j.1365-2559.2010.03686.x · DOI
  25. Li, 2009, Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors, Cancer Cell, 16, 533, 10.1016/j.ccr.2009.10.025 · DOI
  26. Luo, 2009, Down-regulated miR-9 and miR-433 in human gastric carcinoma, J. Exp. Clin. Cancer Res., 28, 82, 10.1186/1756-9966-28-82 · DOI
  27. Oberg, 2011, miRNA expression in colon polyps provides evidence for a multihit model of colon cancer, PLoS One, 6, e20465, 10.1371/journal.pone.0020465 · DOI
  28. Zhu, 2008, MicroRNA-21 targets tumor suppressor genes in invasion and metastasis, Cell Res., 18, 350, 10.1038/cr.2008.24 · DOI · Paper page
  29. Tsai, 2009, MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma, Hepatology, 49, 1571, 10.1002/hep.22806 · DOI
  30. Bai, 2009, MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib, J. Biol. Chem., 284, 32015, 10.1074/jbc.M109.016774 · DOI
  31. Tsang, 2011, P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in hepatocellular carcinoma cells, Apoptosis, 16, 524, 10.1007/s10495-011-0581-5 · DOI
  32. Wang, 2011, miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma, Biochem. Biophys. Res. Commun., 411, 586, 10.1016/j.bbrc.2011.06.191 · DOI
  33. Fang, 2011, MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression, Hepatology, 54, 1729, 10.1002/hep.24577 · DOI
  34. Arzumanyan, 2011, Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?, Cancer Res., 71, 3701, 10.1158/0008-5472.CAN-10-3951 · DOI
  35. Yoon, 2011, Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma, Hum. Pathol., 42, 1391, 10.1016/j.humpath.2010.12.010 · DOI
  36. Gramantieri, 2009, MicroRNA-221 targets Bmf in hepatocellular carcinoma and Correlates with tumor multifocality, Clin. Cancer Res., 15, 5073, 10.1158/1078-0432.CCR-09-0092 · DOI
  37. Li, 2008, Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma, Int. J. Cancer, 123, 1616, 10.1002/ijc.23693 · DOI
  38. Chiang, 2010, PKC alpha mediated induction of miR-101 in human hepatoma HepG2 cells, J. Biomed. Sci., 17, 35, 10.1186/1423-0127-17-35 · DOI
  39. Jiang, 2010, Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma, Int. J. Cancer, 127, 505, 10.1002/ijc.25320 · DOI
  40. Song, 2011, MiR-138 suppresses expression of hypoxia-inducible factor 1 (HIF-1) in clear cell renal cell carcinoma 786-O cells, Asian Pac. J. Cancer Prev., 12, 1307
  41. Liu, 2011, MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines, Biochem. J., 440, 23, 10.1042/BJ20111006 · DOI
  42. Jin, 2011, Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma, J. Biol. Chem., 286, 40104, 10.1074/jbc.C111.296707 · DOI
  43. Jiang, 2011, Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma, Hum. Genet., 129, 189, 10.1007/s00439-010-0915-3 · DOI
  44. Lin, 2001, Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence, Oncogene, 20, 2000, 10.1038/sj.onc.1204375 · DOI
  45. Liu, 2008, The miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes, Nucleic Acids Res., 36, 5391, 10.1093/nar/gkn522 · DOI
  46. Grillo, 2006, Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression, Breast Cancer Res. Treat., 95, 185, 10.1007/s10549-005-9066-y · DOI
  47. Wang, 2006, Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes, Mol. Cell. Biol., 26, 2570, 10.1128/MCB.26.7.2570-2582.2006 · DOI
  48. Liu, 2008, miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes, Nucleic Acids Res., 36, 5391, 10.1093/nar/gkn522 · DOI
  49. Lin, 2001, Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence, Oncogene, 20, 2000, 10.1038/sj.onc.1204375 · DOI
  50. Renate, 2004, Cdk6–cyclin D3 activity in murine ES cells is resistant to inhibition by p16INK4a, Oncogene, 23, 491, 10.1038/sj.onc.1207133 · DOI
  51. Lu, 2011, MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2, Cancer Res., 71, 225, 10.1158/0008-5472.CAN-10-1850 · DOI
  52. Wang, 2011, Enhanced expression of cyclins and cyclin-dependent kinases in aniline-induced cell proliferation in rat spleen, Toxicol. Appl. Pharmacol., 250, 213, 10.1016/j.taap.2010.10.026 · DOI

Cited by

Sorted by citations

See all 182

Metadata

Authors
Wang, W., Zhao, L.-J., Tan, Y.-X., Ren, H., & Qi, Z.-T.
Venue
Carcinogenesis
Publisher
Oxford University Press (OUP)
Published
2012-02-23
Volume
33
Issue
5
Pages
1113-1120
ISSN
  • 1460-2180
  • 0143-3334
DOI
10.1093/carcin/bgs113
PMC
PMC3334515
Cited by
182
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review